Microsoft By The Numbers: Past Performance And Future Valuation Despite a recent dip in the stock price, Microsoft Corporation continues to be a buy based on a strong history of delivering alpha, paired with an updated 5-year target price. Microsoft's past performance has consistently beaten the S&P 500, with a 5-year target price of $771 [...]
Novo Nordisk Breaks Out To An All-Time High On China Approval Of Wegovy As obesity remains a critical global health issue, Eli Lilly's blockbuster drug Zepbound positions the company to potentially become the first trillion-dollar drugmaker, with its market cap already at $858 billion. The strong performance of both Eli Lilly and its competitor Novo [...]
Nvidia Takes The Lead In The Silicon Valley Derby In the ongoing race for market capitalization supremacy, Nvidia, despite being younger than both Apple and Microsoft, has emerged as a formidable contender, recently surpassing both companies. Nvidia has demonstrated impressive performance history and potential, and I project it to double in value over the next [...]
Is It Possible Eli Lilly Is Breaking Out To New All-Time Highs? In my September 2023 article, I recommended Eli Lilly as a buy with a five-year price target of $1,020, driven by the anticipation of its blockbuster drug Mounjaro's approval for weight loss. Since then, the stock has surged by over 40%, and after [...]
Is Nvidia Still The Best Stock In The Market Now? In my August 2023 article, I confidently declared Nvidia the best stock in the market, supported by its remarkable performance and strong valuation. Since then, the stock has surged 61.33%, significantly outpacing the S&P 500's 12.91% gain, and after another outstanding earnings report, I now [...]
Will Eli Lilly and Company Become A Trillion-Dollar Baby? I initially rated Eli Lilly as a buy with a five-year target price of $1,020 per share in September 2023, based on its strong growth potential and valuation. Following the company's impressive earnings report, I’ve revised my target price to $1,318, reflecting an 81.8% upside over [...]
Is Meta Platforms Still A Buy? Meta Platforms, Inc. delivered a stunning Q4 performance with 25% revenue growth and a 203% increase in earnings, surpassing analysts' expectations and driving the stock up by over 20% in a single day. This momentum, combined with strong valuation potential, positions META as a top pick in our Premier [...]
We Were Right About The Market Last Year, What Will 2024 Bring? In 2023, I accurately called the market bottom and benefited from a strong rebound in mega-cap tech stocks after the tough year in 2022. As we head into 2024, I foresee a shift in market dynamics, where smaller, lower P/E stocks may outperform [...]
Is Day Trading Worthwhile? Every investor enters the equity markets with the goal of improving their net worth. Where to begin? There are countless strategies to attempt. Nowadays, greater numbers of individual investors are looking to “day trade” in hopes of gaining big profits. quickly. A simple internet search will uncover hundreds of instructional videos [...]
